FDA Drug Recalls

Recalls / Class II

Class IID-0224-2016

Product

ESTRIOL (E3) W/V (weight/volume) VERSABASE [4714] 0.05% (0.5MG/ML) transdermal cream, dispensed in a) 1 mL and b) 3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Affected lot / code info
a) Lot # 12292014:32@20, Exp 6/27/2015; b) Lot # 01082015:73@21, Exp 7/7/2015

Why it was recalled

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Recalling firm

Firm
the Compounder
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
340 Marshall Ave Unit 100, N/A, Aurora, Illinois 60506-5649

Distribution

Quantity
10 (3mL) syringes, 20 (1mL) syringes
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-03-10
FDA classified
2015-11-10
Posted by FDA
2015-11-18
Terminated
2016-05-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0224-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.